ROCHE DATA ON VERSED USE IN CHILDREN, DEVELOPMENT OF TRANSMUCOSAL AND ORAL FORM REQUESTED BY FDA ANESTHETIC & LIFE SUPPORT DRUGS ADVISORY CMTE.
Executive Summary
Pediatric use data on the I.V. and I.M. formulations of Roche's short-acting benzodiazepine product Versed (midazolam) are being sought by a subcommittee of FDA's Anesthetic & Life Support Drugs Advisory Committee.